Publication | Open Access

PI3K signaling pathway is activated by PIK3CA mRNA overexpression and copy gain in prostate tumors, but PIK3CA, BRAF, KRAS and AKT1 mutations are infrequent events

UrologySignal TransductionSignaling PathwayCopy GainReceptor Tyrosine KinaseAkt1 MutationsTumor SuppressorProstatic DiseaseMedicineRadiation OncologyCell SignalingProstate TumorsTumor Biology